A Budget Impact Model to Evaluate the Economic Impact of Treating Walking Impairment in Chronic Stroke, A US Perspective


Kane S1, Jayawardena N1, Bourque M1, Lavanture J2, Roberts H2
1Eversana, Burlington, ON, Canada, 2MedRhythms, Portland, ME, USA

Presentation Documents

OBJECTIVES: MR-001 is an investigational, at-home rehabilitation system designed to improve walking and ambulation status in adults with chronic stroke. A budget impact model (BIM) was developed to evaluate the economic impact associated with the reimbursement of MR-001 from a US payer perspective.

METHODS: A BIM with a 1-year time horizon was developed to estimate the total costs to payers, including treatment costs and overall healthcare resource use (HCRU) associated with the management of patients with walking impairments in chronic stroke. The model uses a top-down, stroke prevalence- and incidence-based approach and projected market shares for a 1-million member US payer. Current treatment practices available such as physiotherapy, exercise (self-directed), or no treatment are considered in the model; market share estimates are informed by retrospective claims analyses. Impacts to HCRU across treatments are driven by changes in walking speed, based on literature linking improvements of 0.1 m/s in walking speed to an annual HCRU reduction of $1,982.49. The model also considers clinical outcomes, including conversion to community ambulation status. Economic outcomes are calculated as total incremental cost to the payer, costs per-member per-month (PMPM) and per-indicated member per-month (PIMPM).

RESULTS: Reimbursing MR-001 for chronic stroke rehabilitation to improve walking and ambulation status was associated with cost-savings. The cost of MR-001 was offset by the reduction in HCRU driven by the improvement in walking speed associated with the use of MR-001. In sensitivity analyses, further cost-savings were observed when costs associated with recurrent stroke and long-term care home admission were considered.

CONCLUSIONS: There is a significant unmet need in the chronic stroke population for effective treatments to improve walking and reduce HCRU. Results from this BIM suggest that MR-001 should be considered by health plans as a cost-saving intervention to improve walking and ambulation status in people with chronic stroke.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)




Economic Evaluation

Topic Subcategory

Budget Impact Analysis


Medical Devices

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now